1. Home
  2. PCF vs APYX Comparison

PCF vs APYX Comparison

Compare PCF & APYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo High Income Securities Fund

PCF

High Income Securities Fund

HOLD

Current Price

$4.96

Market Cap

95.1M

Sector

Finance

ML Signal

HOLD

Logo Apyx Medical Corporation

APYX

Apyx Medical Corporation

HOLD

Current Price

$2.38

Market Cap

107.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCF
APYX
Founded
N/A
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
95.1M
107.4M
IPO Year
1994
1995

Fundamental Metrics

Financial Performance
Metric
PCF
APYX
Price
$4.96
$2.38
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
★ $6.50
AVG Volume (30 Days)
120.0K
★ 169.8K
Earning Date
01-01-0001
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 19.40
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$12.42
Revenue Next Year
N/A
$11.05
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.92
$2.32
52 Week High
$6.31
$5.08

Technical Indicators

Market Signals
Indicator
PCF
APYX
Relative Strength Index (RSI) 30.63 36.03
Support Level $4.95 $2.33
Resistance Level $5.12 $2.73
Average True Range (ATR) 0.06 0.15
MACD 0.00 0.01
Stochastic Oscillator 26.61 25.00

Price Performance

Historical Comparison
PCF
APYX

About PCF High Income Securities Fund

High Income Securities Fund is a closed-end management investment company. Its primary objective is to provide high current income and capital appreciation is the secondary objective. The Fund pursues its objective mainly by investing in both convertible bonds and convertible preferred stocks. The Fund also invests significantly in high-yielding non-convertible securities with the potential for capital appreciation.

About APYX Apyx Medical Corporation

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Surgical Aesthetics and Original Equipment Manufacturing (OEM). Its Surgical Aesthetics segment derives the majority of its revenue.

Share on Social Networks: